title: Ondansetron: reasons to be restrictive.
authors.forename: C
authors.initials: C
authors.lastname: Frigerio
authors.forename: P A
authors.initials: PA
authors.lastname: Buchwalder
authors.forename: F
authors.initials: F
authors.lastname: Spertini
mesh_terms: D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D017294:Ondansetron / Q000008:administration & dosage / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000932:Antiemetics; D012702:Serotonin Antagonists; D017294:Ondansetron